menu search

89bio: great prospects after excellent phase 2 data

ETNB posted excellent phase 2 data in March. They plan to start a ...

May 28, 2023, 4:18 am

Usdcad weekly analysis – may 27, 2023

The USDCAD currency pair has displayed a resilient uptrend, remaining within a rising price channel on the weekly chart. This upward movement has been...

May 27, 2023, 4:58 am

Gbpusd weekly analysis – may 27, 2023

The GBPUSD currency pair has recently broken below a rising trend line on the weekly chart, indicating that a period of consolidation for the uptrend ...

May 27, 2023, 4:35 am

Eurusd weekly analysis – may 27, 2023

The EURUSD currency pair has entered a consolidation phase within the context of its overall uptrend fr...

May 27, 2023, 4:27 am

Pds biotechnology: promising interim hnscc data reaffirms investment prospects

PDS Biotech's phase 2 study shows potential breakthrough in treating HPV16-positive head and neck cance...

May 27, 2023, 3:40 am

Molecular templates to present on phase i dose escalation study of mt-6402 at the 2023 american society of clinical oncology (asco) annual meeting

AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage ...

May 26, 2023, 9:10 pm

Molecular templates to present on phase i dose escalation study of mt-6402 at the 2023 american society of clinical oncology (asco) annual meeting

AUSTIN, Texas, May 26, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage ...

May 26, 2023, 5:10 pm

Apellis' (apls) study on pegcetacoplan to treat als fails

Apellis' (APLS) phase II MERIDIAN study on pegcetacoplan for the treatment of amyotrophic lateral scler...

May 26, 2023, 12:05 pm

Enphase (enph) launches iq battery 5p in the us and puerto rico

Enphase (ENPH) introduces IQ Battery 5P for customers in the United States and Puerto Rico....

May 26, 2023, 9:05 am

Why is effector therapeutics (eftr) stock up 75% today?

EFFECTOR Therapeutics (NASDAQ: EFTR ) stock is taking off on Friday after the company reported positive data from a ...

May 26, 2023, 8:28 am

Genprex says positive data from acclaim-1 clinical trial to be published at 2023 asco meeting

Genprex Inc. (NASDAQ:GNPX) said positive data from the phase 1 portion of its Acclaim-1 clinical trial ...

May 26, 2023, 8:06 am

Astrazeneca hails the findings from cancer combination trial

AstraZeneca PLC (LSE:AZN) has hailed the potential of a highly targeted combination of its own drugs with chemotherapy in the battle against endometr...

May 26, 2023, 2:41 am

Shattuck labs to present complete dose-escalation data from phase 1a monotherapy clinical trial of sl-172154 in platinum-resistant ovarian cancer (proc) at the american society of clinical oncology (a

– SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pha...

May 25, 2023, 9:15 pm

Shattuck labs to present complete dose-escalation data from phase 1a monotherapy clinical trial of sl-172154 in platinum-resistant ovarian cancer (proc) at the american society of clinical oncology (a

– SL-172154 demonstrated favorable safety and tolerability profile across doses, with maximal CD47 and CD40 target engagement and CD40-dependent pha...

May 25, 2023, 9:15 pm

Springworks therapeutics announces presentation of additional data from phase 3 defi trial of nirogacestat in adults with desmoid tumors at the 2023 asco annual meeting

– Nirogacestat Treatment Demonstrated Rapid, Sustained and Consistent Reductions in Pain Compared to Placebo Using Multiple Assessment Tools – –...

May 25, 2023, 9:05 pm

Fcm concerned mindmed’s mismanagement threatens mental health for millions

MindMed has Slashed Allocation of Spending on Core Drugs While Executive Compensation has Soared to $51M MindMed ...

May 25, 2023, 8:57 pm

Effector therapeutics reports positive data updates from phase 2 expansion cohorts evaluating zotatifin in patients with er+ metastatic breast cancer at the asco 2023 annual meeting

Partial responses observed in 5 of 19 (26%) evaluable patients treated with zotatifin 0.07 mg/kg combined with fulvestrant and abemaciclib (ZFA triple...

May 25, 2023, 8:50 pm

Roche, with ocrevus and fenebrutinib advancement, should be top ms contender

It is expected that the market opportunity for disease-modifying therapies for MS will reach $29.8 billion in 2030; further projected that OCREVUS cou...

May 25, 2023, 7:36 pm

Tesla will bring its supercharger network to ford, a competitor in the ev market, to hep bring the car company to 'equal footing,' elon musk says

During a live audio-only interview on Twitter, Elon Musk and Jim Farley spoke about how to usher in the next p...

May 25, 2023, 6:00 pm


Search within

Pages Search Results: